E-cigarettes for immediate smoking substitution in women diagnosed with cervical dysplasia and associated disorders

International Journal of Environmental Research and Public Health

Volumn 13, Issue 3, 2016, Pages

  James, Shirley A ^a   Meier, Ellen M ^b   Wagener, Theodore L ^b   Smith, Katherine M ^a   Neas, Barbara R ^a   Beebe, Laura A ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical dysplasia; EC; Electronic cigarette; Electronic nicotine delivery device; Smoking cessation; Vaping

Indexed keywords

CANCER; SMOKING; TOBACCO; WOMENS HEALTH;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ELECTRONIC CIGARETTE; FEMALE; FOLLOW UP; HUMAN; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; PATHOPHYSIOLOGY; PREVALENCE; SAMPLE SIZE; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT DURATION; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; WILCOXON SIGNED RANKS TEST; COMPARATIVE STUDY; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; THERAPY; UNITED STATES; UTERINE CERVICAL DYSPLASIA; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

NICOTINE GUM;

ADULT; AGED; AGED, 80 AND OVER; ELECTRONIC CIGARETTES; FEMALE; HUMANS; MIDDLE AGED; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; UNITED STATES; UTERINE CERVICAL DYSPLASIA; YOUNG ADULT;

EID: 84960156621     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13030288     Document Type: Article

References (42)

1. United States Cancer Statistics. 1999–2012 Cancer Incidence and Mortality Data. Available online: https://nccd.cdc.gov/uscs/ (accessed on 8 January 2016).
2. Shiffman, M.; Castle, P.E.; Jeronimo, J.; Rodriquez, A.C.; Wacholder, S. Human papillomavirus. Arch. Pathol. Lab. Med. 2003, 127, 930–934.
3. Walboomers, J.M.; Jacobs, M.; Manos, M. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189, 12–19. [CrossRef]
4. Krebs, H.; Denny, L. Human papillomavirus infection and genital tract cancer. Glob. Libr. Womens Med. 2008. [CrossRef]
5. Castellsaque, X.; Munoz, N. Chapter 3: Cofactors in human papillomavirus carcinogenesis—Role of parity, oral contraceptives, and tobacco smoking. J. Natl. Cancer Inst. Monogr. 2003, 31, 20–28. [CrossRef]
6. Fonseca-Moutinho, J. Smoking and cervical cancer. Obstet. Gynecol. 2011, 2011. [CrossRef] [PubMed]
7. Coker, A.L.; DeSimone, C.P.; Eggleston, K.S.; Hopenhayn, C.; Nee, J.; Tucker, T. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005. Gynecol. Oncol. 2009, 112, 365–369. [CrossRef] [PubMed]
8. US FDA. FDA 101 Smoking Cessation Products.2015. Available online: http://www.fda.gov/downloads/ ForConsumers/ConsumerUpdates/UCM331925.pdf (accessed on 15 December 2015).
9. Centers for Disease Control and Prevention. Cigarette smoking among adults and trends in smoking cessation—United States, 2008. MMWR Morb. Mortal. Wkly. Rep. 2009, 58, 1227–1232.
10. Brown, J.; Beard, E.; Kotz, D.; Michie, S.; West, R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: A cross-sectional population study. Addiction 2014, 109, 1531–1540. [CrossRef] [PubMed]
11. Britton, J.; Bogdanovica, I. Electronic cigarettes: A report commissioned by Public Health England. Available online: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/311887/ Ecigarettes_report.pdf (accessed on 8 January 2016).
12. Caponnetto, P.; Campagna, D.; Cibella, F.; Morjaria, J.B.; Caruso, M.; Russo, C.; Polosa, R. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS ONE. 2013, 8, e66317. [CrossRef] [PubMed]
13. Bullen, C.; Howe, C.; Laugesen, M.; McRobbie, H.; Willman, P.; Walker, N. Electronic cigarettes for smoking cessation: A randomized controlled trial. Lancet 2013, 16, 1629–1637. [CrossRef]
14. Polosa, R.; Caponnetto, P.; Morjaria, J.; Papale, G.; Campagna, D.; Russo, C. Effect of an electronic nicotine delivery device (e-cigareette) on smoking reduction and cessation: A prospective 6-month pilot study. BMC Public Health 2011, 11. [CrossRef] [PubMed]
15. Wagener, T.L.; Meier, E.M.; Hale, J.J. Pilot investigation of changes in readiness and confidence to quit smoking after e-cigarette experimentation and 1 week of use. Nicotine Tob. Res. 2014, 16, 108–114. [CrossRef] [PubMed]
16. Blu® Electronic Cigarettes. A subsidiary of Lorillard, Inc. (NYSE: LO), Charlotte, NC, USA. Available online: www.blucigs.com (accessed on 8 January 2016).
17. Heatherton, T.F.; Kozlowski, L.T.; Frecker, R.C.; Fagerstrom, K.O. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 1991, 86, 1119–1127. [CrossRef] [PubMed]
18. Meneses-Gaya, I.C.; Zuardi, A.W.; Loureiro, S.R.; Crippa, J.A. Psychometric properties of the Fagerstrom test for nicotine dependence. J. Bras. Pneumol. 2009, 35, 73–82. [CrossRef] [PubMed]
19. Boudreaux, E.D.; Sullivan, A.; Abar, B.; Bernstein, S.L.; Ginde, A.A.; Camargo, C.A. Motivation rulers for smoking cessation: A prospective observational examination of construct and predictive validity. Addict. Sci. Clin. Pract. 2012, 7. [CrossRef] [PubMed]
20. West, R.; Stapleton, J. Clinical and public health significance of treatments to aid smoking cessation. Eur. Respir. Rev. 2008, 17, 199–204. [CrossRef]
21. Beiner, L.; Abrams, D.B. The contemplation ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991, 10, 360–365. [CrossRef]
22. Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16, 606–613. [CrossRef] [PubMed]
23. Covey, L.S.; Glassman, A.H.; Stetner, F. Major depression following smoking cessation. Am. J. Psychiatry 1997, 154, 263–265. [PubMed]
24. Lowry, R. Concepts & Applications of Inferential Statistics. Available online: http://vassarstats.net/textbook/ch12a.html (accessed on 12 January 2015).
25. Clinical Guidelines and Recommendations. Available online: http://www.ahrq.gov/professionals/cliniciansproviders/ guidelines-recommendations/index.html (accessed on 8 January 2016).
26. Etter, J.F.; Bullen, C. Electronic cigarette: Users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106, 2017–2028. [CrossRef] [PubMed]
27. Steinberg, M.B.; Zimmermann, M.H.; Delnevo, C.D.; Lewis, M.J.; Shukla, P.; Coups, E.J.; Foulds, J. E-cigarette versus nicotine inhaler: Comparing the perceptions and experiences of inhaled nicotine devices. J. Gen. Intern. Med. 2014, 29, 1444–1450. [CrossRef] [PubMed]
28. Foulds, J.; Veldheer, S.; Berg, A. Electronic cigarettes (e-cigs): Views of aficionados and clinical/public health perspectives. Int. J. Clin. Pract. 2011, 65, 1037–1042. [CrossRef] [PubMed]
29. Etter, J.F. Electronic cigarettes: A survey of users. BMC Public Health 2010, 10. [CrossRef] [PubMed]
30. McQueen, A.; Tower, S.; Sumner, W. Interviews with “vapers”: Implications for future research with electronic cigarettes. Nicotine Tob. Res. 2011, 13, 860–867. [CrossRef] [PubMed]
31. Caponnetto, P.; Auditore, R.; Russo, C.; Cappello, G.C.; Polosa, R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: A prospective 12-month pilot study. Int. J. Environ. Res. Public Health 2013, 10, 446–461. [CrossRef] [PubMed]
32. Pacifici, R.; Pichini, S.; Graziono, S.; Pellegrini, M.; Giuseppina, M.; Beatrice, F. Successful nicotine intake in medical assisted use of E-cigarettes: A pilot study. Int. J. Environ. Res. Public Health 2015, 12, 7638–7646. [CrossRef] [PubMed]
33. Polosa, R.; Caponnetto, P.; Cibella, F.; Le-Houezec, J. Quit and smoking reduction rates in vape shop consumers: A prospective 12-month survey. Int. J. Environ. Res. Public Health 2015, 12, 3428–3438. [CrossRef] [PubMed]
34. Reid, J.L.; Hammond, D.; Boudreau, C.; Fong, G.; Siahpush, M.; The ITC Collaboration. Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western counties: Findings from the International Tobacco Control Four Country Survey. Nicotine Tob. Res. 2010, 12 (Suppl. S1), S20–S33. [CrossRef] [PubMed]
35. U.S. Department of Health & Human Services. 2015 Poverty Guidelines. Available online: http://aspe.hhs.gov/2015-poverty-guidelines (accessed on 10 November 2015).
36. Carpenter, M.J.; Hughes, J.R.; Solomon, L.J.; Callas, P.W. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J. Consult. Clin. Psychol. 2004, 72, 371–381. [CrossRef] [PubMed]
37. Boudreaux, E.D.; Moon, S.; Baumann, B.M.; Carmargo, C.A.; O’Hea, E.; Ziedonis, D.M. Intentions to quit smoking: Causal Attribution, perceived illness severity, and event-related fear during an acute health event. Ann. Behav. Med. 2010, 40, 350–355. [CrossRef] [PubMed]
38. Cobb, N.K.; Abrams, D.B. E-cigarette or drug-delivery device? Regulating novel nicotine products. N. Engl. J. Med. 2011, 365, 193–195. [CrossRef] [PubMed]
39. Yamin, C.K.; Bitton, A. Bates, D.W. E-cigarettes: A rapidly growing internet phenomenon. Ann. Intern. Med. 2010, 153, 607–609. [CrossRef] [PubMed]
40. Lechner, W.V.; Tackett, A.P.; Grant, D.M.; Tahirkkeli, N.N.; Driskill, L.M.; Wagener, T.L. Effects of duration on electronic cigarette use. Nicotine Tob. Res. 2015, 17, 180–185. [CrossRef] [PubMed]
41. Barrueco, M.; Jiménez Ruiz, C.; Palomo, L.; Torrecilla, M.; Romero, P.; Riesco, J.A. Veracity of smokers’ reports of abstinence at smoking cessation clinics. Arch. Bronconeumol. 2005, 41, 135–140. [CrossRef] [PubMed]
42. Studts, J.L.; Ghate, S.R.; Gill, J.L.; Studts, C.R.; Barnes, C.N.; LaJoie, A.S.; Andrykowski, M.A.; LaRocca, M.A. Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1825. [CrossRef] [PubMed]